Stocks
Editas Medicine (EDIT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 571% | 2 206% | 1 786% | 4 249% | 3 765% | 1 755% | |||
| Changes by years, y/y, % | -336pp | +635pp | -420pp | +2 462pp | -484pp | +14.6% | |||
Editas Medicine. R&D/CAPEX, %
Editas Medicine. R&D/CAPEX, changes, pp
Editas Medicine (EDIT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 2 233% | 5 210% | 2 532% | 1 511% | 2.09% | 1 755% | ||
| Changes by years, y/y, % | -4 498pp | -3 123pp | +478pp | -723pp | -2 231pp | |||
| Changes by quarters, q/q, % | -1pp | +2 977pp | -2 677pp | -1 021pp | -1 509pp | |||
